RECRUITING

Smartphone Services for Stimulant Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.

Official Title

Decentralized Clinical Trial of Contingency Management Digital Therapeutic to Treat Stimulant Use Disorder

Quick Facts

Study Start:2025-06-24
Study Completion:2027-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07092059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults who are at least 18 years old, speak/read English, have a smartphone, and who meet criteria for Stimulant Use Disorder, active or early remission. If being discharged to outpatient or intensive outpatient care, the patient is eligible.
  1. * Unwilling to authorize communication with any treatment provider(s), requiring acute detoxification from alcohol or opioids or residential or hospital treatment, or other obstacle to longitudinal participation in the study.
  2. * Currently pregnant

Contacts and Locations

Study Contact

David R Gastfriend, MD
CONTACT
860-679-4689
enrollment@dynamicarehealth.com

Principal Investigator

Carla J Rash, PhD
PRINCIPAL_INVESTIGATOR
UConn Health
David R Gastfriend, MD
PRINCIPAL_INVESTIGATOR
DynamiCare Health Inc.

Study Locations (Sites)

This is an At-Home Study - no travel or on-site visits are needed at all; Main Office: 6 Liberty Sq, #2102
Boston, Massachusetts, 02109
United States

Collaborators and Investigators

Sponsor: DynamiCare Health

  • Carla J Rash, PhD, PRINCIPAL_INVESTIGATOR, UConn Health
  • David R Gastfriend, MD, PRINCIPAL_INVESTIGATOR, DynamiCare Health Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-24
Study Completion Date2027-08

Study Record Updates

Study Start Date2025-06-24
Study Completion Date2027-08

Terms related to this study

Keywords Provided by Researchers

  • cocaine addiction
  • crack addiction
  • methamphetamine addiction
  • cocaine
  • crack
  • methamphetamine
  • stimulants
  • drug problem
  • drug addiction
  • drug abuse

Additional Relevant MeSH Terms

  • Stimulant Use Disorder